STOCK TITAN

Translational Development Acquisition (TDAC) Stock News, Nov 27, 2020

TDAC NASDAQ
Rhea-AI Summary

Trident Acquisitions Corp. (NASDAQ: TDACU, TDAC, TDACW) announced a proxy supplement regarding changes to its timeline for completing a business combination. If approved at the November 30, 2020 stockholder meeting, Trident can extend its deadline by three months, with an additional option for three more months upon board approval. Trident will deposit $0.05 per share for each month of extension, conditional on the stock price. The company also intends to merge with Lottery.com, expected to close in Q1 2021, enhancing Trident's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.84%
Tags

FAQ

What is the current stock price of Translational Development Acquisition (TDAC)?

Translational Development Acquisition (TDAC) last closed at $10.85.

What is the market cap of Translational Development Acquisition (TDAC)?

The market cap of Translational Development Acquisition (TDAC) is approximately $209.5M.